A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The study involves a single oral dose of 18 mg (2 x 9mg tablets) LY2216684 taken on 2
occasions, once with activated charcoal and once without activated charcoal.
The study will evaluate the effect of charcoal on the absorption of LY2216684. Side effects
will be documented. There will be 2 study periods each lasting up to 5 days. There will be at
least 7 days between the two doses and a follow up will occur at least 7 days after the last
dose. Screening is required within 30 days prior to the start of the study.